Repeated Dose Skin Irritation Test for Cosmetics: Standards, Methodology, and Regulatory Application

The repeated dose skin irritation test is a core safety evaluation used to assess the cumulative dermal irritation potential of cosmetics and cosmetic ingredients after repeated skin exposure. Conducted in accordance with frameworks such as China's Safety and Technical Standards for Cosmetics (STSC 2015) and aligned with OECD testing principles, the test supports regulatory registration, new ingredient dossiers, and product safety assessments. This article explains the technical rationale, sample types, methodology, scoring system, and practical applications of the repeated dose skin irritation test for cosmetics.

Technical Overview

The repeated dose skin irritation test (also known as the multiple-dose or cumulative dermal irritation test) evaluates the local irritant effects of a cosmetic product or ingredient when applied to the skin repeatedly over an extended period, typically 14 consecutive days. Unlike a single-application acute irritation study, which captures immediate reactions only, the repeated dose design reflects real-world consumer usage, where leave-on creams, lotions, and serums contact the same skin area day after day.

The test is a standard component of the Safety and Technical Standards for Cosmetics (STSC 2015) issued under China's cosmetics regulatory framework, which also aligns conceptually with internationally recognized dermal toxicity and irritation principles published by the OECD (for example, OECD Test Guideline 404 for acute dermal irritation and OECD Test Guideline 410 for repeated dose dermal toxicity). In the procedure, the test article is applied daily to clipped dorsal skin of healthy rabbits, and dermal responses are scored each day using the Draize grading system for erythema, eschar formation, and edema.

The primary endpoint is the mean daily irritation index, from which a cumulative irritation score is derived and classified on a scale ranging from non-irritant to strongly irritant. The results help formulators, safety assessors, and regulators determine whether a product is suitable for its intended use pattern, particularly for products intended for prolonged or repeated skin contact.

Testing Samples

Leave-On Skin Care Products

Moisturizing creams, facial lotions, essences, eye creams, masks, body butters, and massage products are the most common test articles, because their intended use involves direct, prolonged, and repeated contact with the same skin regions. These products are typically tested undiluted (as supplied) to represent worst-case consumer exposure.

Rinse-Off Products

Shampoos, shower gels, facial cleansers, and hand soaps may also be evaluated when a cumulative irritation profile is required by a regulatory dossier or risk assessment. Depending on the study protocol, rinse-off products can be tested as supplied or diluted to simulate realistic exposure concentrations, with the chosen approach documented in the study plan.

Cosmetic Ingredients and New Raw Materials

Preservatives, surfactants, botanical extracts, functional actives, and other raw materials undergoing new ingredient registration or filing may require repeated dose irritation data as part of the toxicological safety package. Solid or semisolid materials are often moistened with water or a suitable vehicle to ensure adequate skin contact, while liquids are applied directly.

Special-Care and Claim-Sensitive Products

Products intended for sensitive populations or areas, such as infant and children's skin care, eye-area products, and items carrying low-irritation or gentle-use positioning, are frequently subjected to this test to substantiate safety under repeated use. Regulatory authorities may specifically request cumulative irritation evidence for these categories.

Testing Items

The repeated dose skin irritation test measures and documents the following endpoints throughout the dosing and observation periods:

• Erythema and eschar formation, graded on the Draize scale from 0 (no reaction) to 4 (severe erythema with eschar formation)
• Edema (swelling), graded from 0 (no swelling) to 4 (severe swelling extending beyond the application area)
• Additional dermal observations, including dryness, scaling, fissuring, roughness, and hyperplasia, recorded descriptively as supplementary findings
• Daily irritation index, calculated as the average combined erythema and edema score across all animals for each application day
• Cumulative mean irritation index, derived by averaging the daily indices over the entire 14-day dosing period
• Reversibility assessment, documenting whether skin reactions subside after the final application
• General condition monitoring, including body weight, behavior, and any signs of systemic toxicity

Testing Methods

Test System and Preparation

The standard animal model is the healthy adult rabbit, most commonly the New Zealand White strain, with a minimum of three to four animals used per study as prescribed by the STSC 2015 procedure. Approximately 24 hours before the first application, the dorsal fur on both sides of the spine is carefully clipped without abrading the skin, and only animals with intact, healthy skin are selected. Any animal showing pre-existing skin lesions is excluded and replaced.

Dosing Regimen

A defined amount of the test article, typically around 0.5 g for solids and semisolids or 0.5 mL for liquids, is applied to a gauze patch covering an area of approximately 2.5 cm by 2.5 cm on the clipped skin. The patch is secured with a semi-occlusive dressing to maintain contact for about 24 hours. The same application site is treated once daily for 14 consecutive days; before each new application, the site is gently cleaned, residual material is removed, and the fur is re-clipped as needed without injuring the skin. Substances with extreme pH values (for example, pH of 2 or below or 11.5 or above) may be presumed corrosive and excluded from dermal testing on animal welfare grounds.

Scoring and Calculation

Skin reactions are graded daily, generally about one hour after removal of the previous patch and before the next application, using the Draize scoring criteria. The daily irritation index equals the sum of the erythema and edema scores for each animal averaged across all animals on that day. The cumulative irritation index is the average of all daily indices across the full dosing period, providing a single quantitative measure of cumulative irritancy. If severe reactions such as ulceration or necrosis develop, dosing is discontinued for animal welfare reasons, and the test article is classified as a strong irritant or corrosive as appropriate.

Result Classification

Under the classification convention applied in the STSC 2015 framework, the cumulative results are interpreted as follows: a mean score of 0 to below 0.5 is generally regarded as non-irritating, 0.5 to 2.0 as mildly irritating, above 2.0 to 6.0 as moderately irritating, and above 6.0 as strongly irritating. The final conclusion must consider not only the numerical index but also the nature, onset, and reversibility of the observed reactions.

Quality Assurance and Animal Welfare

Studies intended for regulatory submission should be performed under Good Laboratory Practice (GLP) conditions, with documented animal husbandry, calibration records, and raw data traceability. Testing facilities must apply the 3Rs principles (replacement, reduction, and refinement), using the minimum number of animals necessary and humane endpoints. Where accepted by the applicable regulation, validated in vitro methods such as reconstructed human epidermis (RhE) models under OECD Test Guideline 439 should be considered first for acute irritation screening, noting that the European Union prohibits in vivo testing of cosmetic products and ingredients for cosmetics purposes, so in vivo repeated dose studies are relevant primarily in jurisdictions where such testing remains a regulatory requirement.

Applications

The repeated dose skin irritation test serves multiple purposes across the cosmetics product lifecycle:

• New cosmetic ingredient registration and filing dossiers, where cumulative dermal irritation data support the toxicological safety profile required by regulators
• Registration support for special-category cosmetics and products subject to enhanced safety review under national regulations
• Safety assessment of finished products designed for prolonged, repeated, or large-area skin contact, such as daily moisturizers, body lotions, and topical masks
• Formulation optimization during research and development, comparing candidate formulas to select milder ingredient systems and preservative combinations
• Substantiation of low-irritation and gentle-care product positioning, subject to local advertising and claim regulations
• Post-market investigation of consumer complaints and adverse reaction reports, providing scientific evidence for root cause analysis
• Scientific research into cumulative cutaneous toxicity and the development of alternative test methods

FAQ

What is the difference between the repeated dose and the acute skin irritation test?

The acute test involves a single application with observations over a short window, typically up to 72 hours after patch removal. The repeated dose test applies the product daily for 14 consecutive days to the same site, capturing cumulative effects, skin barrier stress, and delayed reactions that a single exposure may not reveal. Products intended for daily use are generally better represented by the repeated dose design.

Which animals are used, and how many are required?

Healthy adult rabbits, typically the New Zealand White strain, are the standard model. The STSC 2015 procedure generally specifies a minimum of three to four animals, with the final number defined in the study protocol and justified on scientific and animal welfare grounds.

How are the results calculated and classified?

Daily erythema and edema scores are summed for each animal, averaged across animals to obtain a daily irritation index, and then averaged over the 14 days to yield the cumulative index. Mean scores below 0.5 are typically classified as non-irritating, 0.5 to 2.0 as mildly irritating, above 2.0 to 6.0 as moderately irritating, and above 6.0 as strongly irritating, with professional judgment applied to the overall reaction pattern.

How long does a typical study take?

The in-life phase, including acclimatization, clipping, and 14 days of dosing, usually requires about three weeks, and a full study cycle including report finalization typically takes four to six weeks depending on laboratory scheduling and any required observation extensions.

Can in vitro methods replace this test?

Validated in vitro alternatives, such as reconstructed human epidermis models under OECD Test Guideline 439, are accepted in many jurisdictions for acute irritation assessment, but they do not yet fully model the cumulative, repeated exposure scenario. Where regulations permit animal testing and require repeated dose data, the in vivo study remains the reference method, while the European Union maintains a full ban on animal testing for cosmetics.

What sample quantity and documentation should be prepared?

Sponsors generally provide a sufficient quantity of the finished product or ingredient, commonly on the order of 50 to 100 grams or milliliters, together with the product formula, ingredient concentrations, physical and chemical specifications, production process description, and intended use instructions, so that the laboratory can design a scientifically justified protocol.